Valuation dashboard for Lucyd, Inc (LUCY) with P/E N/A, P/B 0.77, EV/EBITDA -0.38 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Analysis Summary
Lucyd, Inc reported revenue of $2.7M in the most recent fiscal year, growing at a 5-year CAGR of 115.7%.
Trailing-twelve-month margins: gross margin 22.8%, operating margin -249.0%, net margin -225.3%.
At the current price of $0.86, LUCY has negative trailing earnings (P/E not meaningful) and an ROE of -88.90%. Market capitalisation stands at $5M.
Balance sheet quality for LUCY: current ratio of 9.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.77 |
| EV / EBITDA | -0.38 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-19.88 |
| vs Current Price | -2410.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| LUCY | Lucyd, Inc | $5M | 0.77 | -88.9% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $31.1B | |||
| MDLN | Medline Inc. | $27.6B | 38.36 | 2.44 | 10.8% |
Price
| Price | $0.86 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -88.90% |
| Return on Invested Capital | -122.15% |
| Return on Assets | -102.86% |
| Gross Margin | 22.79% |
| Operating Margin | -249.03% |
| Net Margin | -225.28% |
Related companies: APRE · BCDA · BMRA · CELZ · CHEK · KPRX · MHUA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of LUCY: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks